​​

​Program Overview

The Second Middle East Lung Cancer Congress is a platform for discussing recent advances in understanding the pathophysiology of lung cancer. It will enhance multidisciplinary collaboration between various specialties involved in the care of lung cancer patients.

• Provide a multidisciplinary (MDT) approach to patients with lung cancer that involves the pathologists, pulmonologist, thoracic surgeon as well as medical oncologist; MDT is the new standard of approach and this conference aims at showing the benefit of this approach.
  

• Discuss recent advances in lung cancer therapy for both non-small cell lung cancer and small cell lung cancer.

• Better understand recent therapies mechanism of action and toxicities and new treatment modalities such as immunotherapy.
  

Target Audience​

This congress targets medical oncologists, radiation oncologists, surgeons, radiologists, pathologists, pulmonologists, residents, fellows, nurses and medical students.